Articles

1. Cardiovascular Health and Disease in the Pakistani American Population

   • Murrium I. Sadaf
   • Usman Ali Akbar
   • Safi U. Khan

   Review 26 April 2024

   

2. Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus

   • Reed Mszar
   • Miriam E. Katz
   • Michael J. Blaha

   Review 25 April 2024

   

3. What Causes Premature Coronary Artery Disease?

   • Ann Le
   • Helen Peng
   • Guillaume Paré

   Review 04 April 2024

   

4. Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials

   • Cosimo Andrea Stamerra
   • Paolo Di Giosia
   • Amirhossein Sahebkar

   Review 02 April 2024

   

5. Oral PCSK9 Inhibitors

   • Anandita Agarwala
   • Ramsha Asim
   • Christie M. Ballantyne

   Review 27 March 2024

6. Gene Editing for the Treatment of Hypercholesterolemia

   • Menno Hoekstra
   • Miranda Van Eck

   Review Open access 18 March 2024

   

7. The Role of Genetics in Advancing Cardiometabolic Drug Development

   • Roukoz Abou-Karam
   • Fangzhou Cheng
   • Akl C. Fahed

   Review 07 March 2024

   

8. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions

   • Melody Hermel
   • Andrew Chiou
   • Salim S. Virani

   Review 05 March 2024 Pages: 119 - 131

9. European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges

   • Angela Pirillo
   • Lale Tokgözoğlu
   • Alberico L. Catapano

   Review 02 March 2024

   

10. Implications of Bias in Artificial Intelligence: Considerations for Cardiovascular Imaging

    • Marly van Assen
    • Ashley Beecy
    • Judy Gichoya

    Review 16 February 2024 Pages: 91 - 102

    

11. Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment

    • Anders Berg Wulff
    • Børge G. Nordestgaard
    • Anne Langsted

    Review 05 February 2024 Pages: 111 - 118

    

12. How Will Our Practice Change After the CLEAR Outcomes Trial?

    • Timothy Abrahams
    • Adam J. Nelson
    • Stephen J. Nicholls

    Review Open access 31 January 2024 Pages: 83 - 89

    

13. Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy

    • Vojtech Kratky
    • Anna Valerianova
    • Jan Malik

    Review 30 January 2024 Pages: 103 - 109

    

14. Lipoprotein(a): from Causality to Treatment

    • Florian Kronenberg

    Review Open access 22 January 2024 Pages: 75 - 82

    

15. Correction to: Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?

    • Stanisław Surma
    • Amirhossein Sahebkar
    • Maciej Banach

    Author Correction Open access 22 January 2024 Pages: 73 - 73

16. Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan

    • Allison E. Gaffey
    • Erica S. Spatz

    Review 19 January 2024 Pages: 45 - 58

    

17. Targeting the Gut Microbiome to Treat Cardiometabolic Disease

    • Panagiotis Theofilis
    • Panayotis K. Vlachakis
    • Dimitris Tousoulis

    Review 05 January 2024 Pages: 25 - 34

    

18. Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?

    • Stanisław Surma
    • Amirhossein Sahebkar
    • Maciej Banach

    Review Open access 02 January 2024 Pages: 59 - 71

    

19. Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

    • John W. Ostrominski
    • Tiffany M. Powell-Wiley

    Review 30 December 2023 Pages: 11 - 23

    

20. Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes

    • Jingjing Zhu
    • John P. H. Wilding

    Review Open access 27 December 2023 Pages: 1 - 10

    

21. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

    • John J. P. Kastelein
    • Andrew Hsieh
    • Michael H. Davidson

    Review Open access 22 December 2023 Pages: 35 - 44

    

22. How to Handle Elevated Triglycerides: Life after PROMINENT

    • Angela Pirillo
    • Alberico L. Catapano

    Review 20 December 2023 Pages: 921 - 929

    

23. Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity

    • Krunal Amin
    • Garrett Bethel
    • Caroline E. Sloan

    Review 18 December 2023 Pages: 1113 - 1127

    

24. Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia

    • Miriam Larouche
    • Etienne Khoury
    • Daniel Gaudet

    Review 14 December 2023 Pages: 1101 - 1111

    

25. Machine Learning in Invasive and Noninvasive Coronary Angiography

    • Ozan Unlu
    • Akl C. Fahed

    Review 14 December 2023 Pages: 1025 - 1033

    

26. Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?

    • Steve E Humphries
    • Uma Ramaswami
    • Neil Hopper

    Review 07 December 2023 Pages: 1083 - 1091

    

27. Sex Differences in Cardiac Transplantation

    • Alice Chung
    • Heidi Hartman
    • Ersilia M. DeFilippis

    Review 07 December 2023 Pages: 995 - 1001

    

28. HDL as a Treatment Target: Should We Abandon This Idea?

    • Floran Begue
    • Marie Laurine Apalama
    • Olivier Meilhac

    Review 05 December 2023 Pages: 1093 - 1099

    

29. Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management

    • Zulqarnain Javed
    • Harun Kundi
    • Hassaan Arshad

    Review 04 December 2023 Pages: 1059 - 1068

    

30. Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease

    • Yulith Roca Alvarez
    • Madison Pico
    • Odayme Quesada

    Review 04 December 2023 Pages: 1003 - 1011

    

31. Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?

    • Hana Poloczková
    • Jan Krejčí

    Review 04 December 2023 Pages: 957 - 964

32. Emerging Preventive Strategies in Chronic Kidney Disease: Recent Evidence and Gaps in Knowledge

    • Nishigandha Pradhan
    • Mirela Dobre

    Review 01 December 2023 Pages: 1047 - 1058

    

33. Natural Sirtuin1 Activators and Atherosclerosis: an Overview

    • Karolina Łanoszka
    • Nimasha Vlčková

    Review Open access 01 December 2023 Pages: 979 - 994

34. Caregiver Influences on Eating Behaviors in Children: An Opportunity for Preventing Obesity

    • Lorraine M. Schratz
    • Olivia Larkin
    • Christine Martin

    Review 30 November 2023 Pages: 1035 - 1045

    

35. Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)

    • Natalie Arnold
    • Wolfgang Koenig

    Review Open access 28 November 2023 Pages: 939 - 946

    

36. Machine Learning in Cardiovascular Risk Prediction and Precision Preventive Approaches

    • Nitesh Gautam
    • Joshua Mueller
    • Subhi J. Al’Aref

    Review 27 November 2023 Pages: 1069 - 1081

    

37. Gene Regulatory Networks in Coronary Artery Disease

    • Jenny Cheng
    • Michael Cheng
    • Xia Yang

    Review 27 November 2023 Pages: 1013 - 1023

    

38. Obesity and Dyslipidemia

    • Barbora Nussbaumerova
    • Hana Rosolova

    Review 18 November 2023 Pages: 947 - 955

39. Rap1 in the Context of PCSK9, Atherosclerosis, and Diabetes

    • Heena Agarwal
    • Brea Tinsley
    • Lale Ozcan

    Review 18 November 2023 Pages: 931 - 937

40. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress

    • Kartik Gupta
    • Colin Hinkamp
    • Salim S. Virani

    Review 17 November 2023 Pages: 965 - 978

41. Coronary and Extra-coronary Subclinical Atherosclerosis to Guide Lipid-Lowering Therapy

    • Jelani K. Grant
    • Carl E. Orringer

    Review 16 November 2023 Pages: 911 - 920

    

42. Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing

    • Pablo Corral
    • Carlos A. Aguilar Salinas
    • Laura Schreier

    ReviewPaper 03 November 2023 Pages: 899 - 909

    

43. The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations

    • E. Avenatti
    • J. A. Carrasco-Avila
    • K. Nasir

    ReviewPaper 26 October 2023 Pages: 889 - 898

44. Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies

    • Asier Larrea-Sebal
    • Shifa Jebari-Benslaiman
    • César Martín

    ReviewPaper Open access 17 October 2023 Pages: 839 - 859

    

45. Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems

    • Maciej Banach
    • Giuseppe Danilo Norata

    Review Open access 13 October 2023 Pages: 879 - 888

46. Sex Differences in Familial Hypercholesterolemia

    • Marianne Klevmoen
    • Janneke W.C.M. Mulder
    • Kirsten B. Holven

    ReviewPaper Open access 10 October 2023 Pages: 861 - 868

    

47. Percutaneous Coronary Interventions in Women

    • Golsa Joodi
    • Sristi Palimar
    • Marcella Calfon Press

    Review Open access 10 October 2023 Pages: 829 - 837

48. Mechanisms Behind NAFLD: a System Genetics Perspective

    • Shirin Pourteymour
    • Christian A. Drevon
    • Frode A. Norheim

    Review 09 October 2023 Pages: 869 - 878

    

49. Statin Use and Coronary Artery Calcification: a Systematic Review and Meta-analysis of Observational Studies and Randomized Controlled Trials

    • Mitra Nekouei Shahraki
    • Soroush Mohammadi Jouabadi
    • Fariba Ahmadizar

    ReviewPaper Open access 05 October 2023 Pages: 769 - 784

50. Updates in Small Interfering RNA for the Treatment of Dyslipidemias

    • S. Carugo
    • C. R. Sirtori
    • M. Ruscica

    ReviewPaper Open access 04 October 2023 Pages: 805 - 817